BIOTON S.A. (WSE:BIO)

Poland flag Poland · Delayed Price · Currency is PLN
3.630
-0.040 (-1.09%)
Apr 24, 2025, 1:59 PM CET
3.13%
Market Cap 315.12M
Revenue (ttm) 207.76M
Net Income (ttm) -15.66M
Shares Out 85.86M
EPS (ttm) -0.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 9,700
Average Volume 31,138
Open 3.670
Previous Close 3.670
Day's Range 3.610 - 3.670
52-Week Range 2.795 - 3.800
Beta 0.41
RSI 51.57
Earnings Date Mar 28, 2025

About BIOTON

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 359
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BIO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.